171 related articles for article (PubMed ID: 28844735)
1. Pseudo-peptide amyloid-β blocking inhibitors: molecular dynamics and single molecule force spectroscopy study.
Mehrazma B; Robinson M; Opare SKA; Petoyan A; Lou J; Hane FT; Rauk A; Leonenko Z
Biochim Biophys Acta Proteins Proteom; 2017 Nov; 1865(11 Pt B):1707-1718. PubMed ID: 28844735
[TBL] [Abstract][Full Text] [Related]
2. Testing synthetic amyloid-β aggregation inhibitor using single molecule atomic force spectroscopy.
Hane FT; Lee BY; Petoyan A; Rauk A; Leonenko Z
Biosens Bioelectron; 2014 Apr; 54():492-8. PubMed ID: 24321883
[TBL] [Abstract][Full Text] [Related]
3. In silico investigation and targeting of amyloid β oligomers of different size.
Autiero I; Saviano M; Langella E
Mol Biosyst; 2013 Aug; 9(8):2118-24. PubMed ID: 23708585
[TBL] [Abstract][Full Text] [Related]
4. Interaction Dynamics in Inhibiting the Aggregation of Aβ Peptides by SWCNTs: A Combined Experimental and Coarse-Grained Molecular Dynamic Simulation Study.
Lin D; Qi R; Li S; He R; Li P; Wei G; Yang X
ACS Chem Neurosci; 2016 Sep; 7(9):1232-40. PubMed ID: 27441457
[TBL] [Abstract][Full Text] [Related]
5. De novo design of self-assembled hexapeptides as β-amyloid (Aβ) peptide inhibitors.
Wang Q; Liang G; Zhang M; Zhao J; Patel K; Yu X; Zhao C; Ding B; Zhang G; Zhou F; Zheng J
ACS Chem Neurosci; 2014 Oct; 5(10):972-81. PubMed ID: 25133634
[TBL] [Abstract][Full Text] [Related]
6. Atomic force microscopy and MD simulations reveal pore-like structures of all-D-enantiomer of Alzheimer's β-amyloid peptide: relevance to the ion channel mechanism of AD pathology.
Connelly L; Jang H; Arce FT; Capone R; Kotler SA; Ramachandran S; Kagan BL; Nussinov R; Lal R
J Phys Chem B; 2012 Feb; 116(5):1728-35. PubMed ID: 22217000
[TBL] [Abstract][Full Text] [Related]
7. Specific keratinase derived designer peptides potently inhibit A
Rajput R; G L B; Srivastava A; Wahi D; Shrivastava N; Kundu B; Grover A
Biochem J; 2019 Jun; 476(12):1817-1841. PubMed ID: 31138770
[TBL] [Abstract][Full Text] [Related]
8. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
Nguyen P; Derreumaux P
Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046
[TBL] [Abstract][Full Text] [Related]
9. Structures of Aβ17-42 trimers in isolation and with five small-molecule drugs using a hierarchical computational procedure.
Chebaro Y; Jiang P; Zang T; Mu Y; Nguyen PH; Mousseau N; Derreumaux P
J Phys Chem B; 2012 Jul; 116(29):8412-22. PubMed ID: 22283547
[TBL] [Abstract][Full Text] [Related]
10. The molecular mechanism of fullerene-inhibited aggregation of Alzheimer's β-amyloid peptide fragment.
Xie L; Luo Y; Lin D; Xi W; Yang X; Wei G
Nanoscale; 2014 Aug; 6(16):9752-62. PubMed ID: 25004796
[TBL] [Abstract][Full Text] [Related]
11. Structural, morphological, and kinetic studies of β-amyloid peptide aggregation on self-assembled monolayers.
Wang Q; Shah N; Zhao J; Wang C; Zhao C; Liu L; Li L; Zhou F; Zheng J
Phys Chem Chem Phys; 2011 Sep; 13(33):15200-10. PubMed ID: 21769359
[TBL] [Abstract][Full Text] [Related]
12. Molecular Mechanism and Kinetics of Amyloid-β
Man VH; He X; Ji B; Liu S; Xie XQ; Wang J
ACS Chem Neurosci; 2019 Nov; 10(11):4643-4658. PubMed ID: 31660732
[TBL] [Abstract][Full Text] [Related]
13. Pseudopeptide Amyloid Aggregation Inhibitors: In Silico, Single Molecule and Cell Viability Studies.
Robinson M; Lou J; Mehrazma B; Rauk A; Beazely M; Leonenko Z
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494369
[TBL] [Abstract][Full Text] [Related]
14. Inhibiting and Remodeling Toxic Amyloid-Beta Oligomer Formation Using a Computationally Designed Drug Molecule That Targets Alzheimer's Disease.
Downey MA; Giammona MJ; Lang CA; Buratto SK; Singh A; Bowers MT
J Am Soc Mass Spectrom; 2019 Jan; 30(1):85-93. PubMed ID: 29713966
[TBL] [Abstract][Full Text] [Related]
15. Alpha-helix targeting reduces amyloid-beta peptide toxicity.
Nerelius C; Sandegren A; Sargsyan H; Raunak R; Leijonmarck H; Chatterjee U; Fisahn A; Imarisio S; Lomas DA; Crowther DC; Strömberg R; Johansson J
Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9191-6. PubMed ID: 19458258
[TBL] [Abstract][Full Text] [Related]
16. Designing a new multifunctional peptide for metal chelation and Aβ inhibition.
Shamloo A; Asadbegi M; Khandan V; Amanzadi A
Arch Biochem Biophys; 2018 Sep; 653():1-9. PubMed ID: 29906409
[TBL] [Abstract][Full Text] [Related]
17. Amyloid peptide Aβ40 inhibits aggregation of Aβ42: evidence from molecular dynamics simulations.
Viet MH; Li MS
J Chem Phys; 2012 Jun; 136(24):245105. PubMed ID: 22755606
[TBL] [Abstract][Full Text] [Related]
18. A solution NMR toolset to probe the molecular mechanisms of amyloid inhibitors.
Ahmed R; Melacini G
Chem Commun (Camb); 2018 May; 54(37):4644-4652. PubMed ID: 29658548
[TBL] [Abstract][Full Text] [Related]
19. In situ monitoring Alzheimer's disease β-amyloid aggregation and screening of Aβ inhibitors using a perylene probe.
Li M; Zhao C; Yang X; Ren J; Xu C; Qu X
Small; 2013 Jan; 9(1):52-5. PubMed ID: 22976818
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for Aβ1–42 toxicity inhibition by Aβ C-terminal fragments: discrete molecular dynamics study.
Urbanc B; Betnel M; Cruz L; Li H; Fradinger EA; Monien BH; Bitan G
J Mol Biol; 2011 Jul; 410(2):316-28. PubMed ID: 21621545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
